Matthew Weinberg Writes for International Clinical Trials (ICT) Magazine

  • August 16, 2013
  • |

In this article CEO Matthew Weinberg discusses the downsides to self-auditing good clinical practice and the need smaller, more proactive audits, on the other hand, can provide a more intelligent analysis. READ MORE...

FDA Hears Recommendations on Updating Trial Regs

  • June 5, 2012
  • |

The June 2012 issue of the Journal of Clinical Research Best Practices covered CEO Matthew Weinberg’s presentation at the April 23 FDA clinical trials hearing. The article, entitled “FDA Hears Recommendations on Updating Trial Regs,” focused on Weinberg’s emphasis on the importance of independent clinical trial auditing. For more information on The Weinberg Group’s independent […] READ MORE...

CEO Matthew Weinberg Presents at FDA Clinical Trials Hearing

  • April 23, 2012
  • |

April 23 – The Weinberg Group CEO, Matthew Weinberg, presented today at FDA’s hearing titled “Modernizing the Regulation of Clinical Trials and Approaches to Good Clinical Practice.”  Mr. Weinberg presented on the mandatory need for audits and audit independence.  A full copy of his presentation can be found below. For more information on The Weinberg […] READ MORE...

The Weinberg Group to Sponsor and Participate in Linking Leaders Roundtable Series

  • March 1, 2012
  • |

Linking Leaders’ Clinical Quality roundtable series provides pharmaceutical and biotech executives a forum to share insights and experiences, benchmark progress, and collaborate on solutions with like-minded peers facing similar industry obstacles in a closed-door, invitation-only setting. This unique forum brings together an exclusive community of executives engaged in Clinical Quality Assurance, Compliance, Risk Management and […] READ MORE...